For the year ending 2025-12-31, OCUL had $344,958K increase in cash & cash equivalents over the period. -$216,893K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Revenue | 51,951 |
| Cost of product revenue | 6,574 |
| Direct program expenses, axpaxli for wet amd | 119,609 |
| Direct program expenses, axpaxli for npdr | 4,804 |
| Direct program expenses, other clinical and preclinical programs | 3,582 |
| Unallocated expenses, personnel costs | 39,255 |
| Unallocated expenses, all other costs | 7,527 |
| Selling & marketing | 48,510 |
| General & administrative | 37,377 |
| Facilities | 7,223 |
| Stock-based compensation | 43,184 |
| Depreciation | 4,323 |
| Interest income | 18,355 |
| Interest expense | 11,835 |
| Other non-operating items | -2,442 |
| Net loss | -265,939 |
| Stock-based compensation expense | 43,184 |
| Non-cash interest expense | 3,397 |
| Change in fair value of derivative liabilities | -2,471 |
| Depreciation and amortization expense | 4,323 |
| Gains and losses on disposal of items of property and equipment | 29 |
| Accounts receivable, net | -1,738 |
| Prepaid expenses and other current assets | -2,602 |
| Inventory | 524 |
| Accounts payable | -887 |
| Operating lease assets | -1,307 |
| Accrued expenses | 5,248 |
| Deferred revenue | -128 |
| Operating lease liabilities | -1,646 |
| Net cash used in operating activities | -204,883 |
| Purchases of property and equipment | 12,010 |
| Proceeds from sales of property and equipment | 130 |
| Net cash used in investing activities | -11,880 |
| Proceeds from exercise of stock options | 20,544 |
| Proceeds from issuance of common stock pursuant to employee stock purchase plan | 1,592 |
| Proceeds from issuance of common stock upon public offering, net of issuance costs | 539,585 |
| Net cash provided by financing activities | 561,721 |
| Net increase in cash, cash equivalents and restricted cash | 344,958 |
| Cash and cash equivalents at beginning of period | 393,716 |
| Cash and cash equivalents at end of period | 738,674 |
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)